Ajanta Pharma Quarterly Results for Trading Insights
AJANTPHARM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹260 Cr
QSept 2025
Ajanta Pharma Quarterly Results Key Highlights
- Revenue of ₹1,413 Cr in Sept 2025 (+18.8% vs Mar 2025, +17.2% vs Sept 2024)
- Net Profit of ₹260 Cr in Sept 2025 (+15.6% vs Mar 2025, +19.8% vs Sept 2024)
- EBITDA of ₹387 Cr in Sept 2025 (+22.9% vs Mar 2025)
- Operating Margin of 24.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹20.83 in Sept 2025 (+15.7% vs Mar 2025)
Ajanta Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1,413 | 1,189 | 1,329 | 1,400 | 1,206 | 18.8% | 17.2% |
| Net Profit (₹ Cr) | 260 | 225 | 255 | 274 | 217 | - | - |
| EBITDA (₹ Cr) | 387 | 315 | 378 | 407 | 331 | - | - |
| EPS (₹) | 20.83 | 18.00 | 20.44 | 21.91 | 17.27 | - | - |
| Operating Margin (%) | 24.0% | 25.0% | 27.0% | 28.0% | 26.0% | - | - |
Ajanta Pharma Share Price Trend Around Quarterly Results
Visualize Ajanta Pharma's 1-year price movement across quarterly results — ideal for logging trades in Ajanta Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Ajanta Pharma
Additional stock information and data for AJANTPHARM
Revenue Trend (₹ Cr)
Dec 2025
1,400
Jun 2025
1,329
Mar 2025
1,189
Sept 2025
1,413
Net Profit Trend (₹ Cr)
Dec 2025
274
Jun 2025
255
Mar 2025
225
Sept 2025
260
Operating Margin Trend (%)
Dec 2025
28.0%
Jun 2025
27.0%
Mar 2025
25.0%
Sept 2025
24.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Ajanta Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1714.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.9 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6185.0 | 2,860 | 689 | +7.1% | - | 24.1% | 238.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4077.2 | 3,219 | 591 | +11.3% | - | 18.4% | 232.5 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1330.0 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1274.9 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores